Home
About
FAQ
History (7)
IL13RA2 targeted alpha particle therapy against glioblastomas.
Nitric Oxide Synthase Type II
Retirement
Phase 1 experience with an anti-glycotope monoclonal antibody, RAV12, in recurrent adenocarcinoma.
Burden, Susan
See All 7 Pages
Find People
Find Everything
Edit My Profile
My Person List (
0
)
Return to Top
Login
Username
Password